• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “high-alpha-capital” Archives

          in
          Entry Author Date Location
          Sigstr Snags $4M Funding Round as Marketing Tech Sector Gets Hotter Sarah Schmid Stevenson 09/21/18 Indiana
          Bessemer Makes First Indiana Investment, Leads Zylo’s $9.3M Series A Sarah Schmid Stevenson 01/31/18 Indiana
          After Quadrupling in Size, Lessonly Raises $8M Series B Sarah Schmid Stevenson 11/16/17 Indiana
          Marketing Startup Sigstr Gets $5M From Hyde Park, HubSpot & Others Jeff Bauter Engel 08/22/17 Indiana
          Text Me: ClearScholar Grabs $1.25M for App to Engage College Kids Sarah Schmid Stevenson 01/05/17 Indiana
          Silicon Valley VCs, Software Experts Contribute $3.3M to Zylo Sarah Schmid Stevenson 10/13/16 Indiana
          Doxly Raises $2.25 Million Seed Round and Plans Public Launch Sarah Schmid Stevenson 09/21/16 Indiana
          Octiv Snags Backing from GE Ventures, Plans to Continue Expansion Sarah Schmid Stevenson 09/13/16 Indiana
          Enterprise Software Startup DroneDeploy Closes $20M Series B Round Sarah Schmid Stevenson 09/08/16 Indiana
          ExactTarget Alums Aim Big With Indianapolis Startup Studio High Alpha Jeff Bauter Engel 04/06/16 Indiana
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Xcelerating Life Sciences San Francisco: Special Report

            From Our Editors · Special Report

            Xcelerating Life Sciences San Francisco: Special Report

            The AI, Big Data, and R&D Boom

          • Biotech Startups: How to Succeed in a COVID-19 World

            Xconomy Insight · Special Report

            Biotech Startups: How to Succeed in a COVID-19 World

            Industry experts explain what it takes to launch a new biotech company

          • What’s Next in Neuroscience Therapies

            Sponsored · Whitepaper

            What’s Next in Neuroscience Therapies

            New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.